Stay in the loop

AlmirallShare new call is seeking new partenship opportunities for preclinical and clinical stage assets that can become new treatments for skin diseases

Almirall and Inserm Transfert enter into a licensing and research collaboration to develop innovative treatments for vitiligo

Almirall announces a collaboration with the University of Michigan to gain understanding of disease drivers in hidradenitis suppurativa